Could a simple monitor transform blood sugar control for millions with type 2 diabetes?
NCT ID NCT06601166
First seen Jun 30, 2026 · Last updated Aug 12, 2026 · Updated 3 times
Summary
This study tests whether using a continuous glucose monitor (CGM) helps adults with type 2 diabetes who do not take insulin improve their blood sugar control. Participants are randomly assigned to either use a real-time CGM or receive routine care with occasional blinded CGM wear. The main goal is to see if CGM use leads to better HbA1c levels after 26 weeks compared to standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Continuous Glucose Monitor (device)
- What this could lead to
- If successful, this could show that continuous glucose monitors help people with type 2 diabetes not on insulin better manage their blood sugar levels in a primary care setting.
- What could go wrong
- This is a relatively small, 26-week study, so long-term benefits or risks are not yet known. The device may not lead to meaningful improvements for all participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Alliance Medical Ministry
Raleigh, North Carolina, 27610, United States
-
Centricity Research
Columbus, Ohio, 43213, United States
-
Cope Family Medicine Ogden Clinic
Bountiful, Utah, 84010, United States
-
Cross Creek Medical Center
Fayetteville, North Carolina, 28304, United States
-
East Coast Institute for Research
Lake City, Florida, 32055, United States
-
East Northport Medical Care
East Northport, New York, 11731, United States
-
Institute of Endocrinology, Diabetes, Health and Hormone
Stockbridge, Georgia, 30281, United States
-
International Diabetes Center
Saint Louis Park, Minnesota, 55416, United States
-
Jefferson City Medical Group
Jefferson City, Missouri, 65109, United States
-
Lucas Research
Morehead City, North Carolina, 28557, United States
-
Medical Care-Avacare
Elizabethton, Tennessee, 37643, United States
-
Mountain State Diabetes
Parkersburg, West Virginia, 26101, United States
-
Ogden Clinic Grand View
Roy, Utah, 84067, United States
-
Riverside Family Medicine Residency
Newport News, Virginia, 23601, United States
-
Tekton Research
Denver, Colorado, 80238, United States
-
Tekton Research
Moore, Oklahoma, 73160, United States
-
Tekton Research - Austin
Austin, Texas, 78705, United States
-
Texas Tech University Health Sciences Center
Lubbock, Texas, 79430, United States
-
Texas Tech University Health Sciences Center
Odessa, Texas, 79763, United States
-
The South Bend Clinic
South Bend, Indiana, 46617, United States
-
University of Colorado, Anschutz Medical Campus, Department of Family Medicine, Primary Care Diabetes Lab
Aurora, Colorado, 80045, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes
- Can a single pill tackle both fatty liver and diabetes?
- Does when you eat carbs and protein reshape blood sugar control?